• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗胆碱能药物对迟发性运动障碍及伴发药物性帕金森综合征患者的影响。

Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism.

作者信息

Wirshing W C, Freidenberg D L, Cummings J L, Bartzokis G

机构信息

Brentwood Movement Disorders Laboratory, UCLA School of Medicine.

出版信息

J Clin Psychopharmacol. 1989 Dec;9(6):407-11.

PMID:2574192
Abstract

Twenty-five percent of 80 consecutive patients who met research criteria for persistent tardive dyskinesia (TD) were found to have an energy peak in the parkinsonian tremor band (3-6 Hz) of the frequency spectrum of their machine-measured resting hand movements in addition to the abnormalities consistent with TD (increased energy in the 0.5-3 Hz frequency spectrum). Twelve of these patients were studied again in double-blind fashion 2 hours after receiving a placebo and again 2 hours after a single 4 mg dose of trihexyphenidyl hydrochloride (HCl). Compared with the placebo condition, the trihexyphenidyl HCl markedly diminished the measured energy in the 4 Hz band and had no effect or slightly decreased the energy at all other points on the frequency spectrum. Simultaneous Abnormal Involuntary Movement Scale ratings revealed no change in the dyskinetic movements between the conditions; there was a significant subjective improvement reported by the patients following the trihexyphenidyl HCl administration. These observations indicate that electromechanical devices identify a subpopulation of TD patients who may acutely benefit from anticholinergic treatment.

摘要

在连续80例符合持续性迟发性运动障碍(TD)研究标准的患者中,25%的患者除了具有与TD一致的异常(0.5 - 3Hz频谱能量增加)外,还发现在其机器测量的静息手部运动频谱的帕金森震颤频段(3 - 6Hz)存在能量峰值。其中12例患者在接受安慰剂2小时后以及单次服用4mg盐酸苯海索(HCl)2小时后,以双盲方式再次接受研究。与安慰剂状态相比,盐酸苯海索显著降低了4Hz频段测量的能量,对频谱上所有其他点的能量没有影响或略有降低。同时,异常不自主运动量表评分显示不同状态下运动障碍性运动没有变化;患者在服用盐酸苯海索后报告有明显的主观改善。这些观察结果表明,机电设备识别出了一部分可能从抗胆碱能治疗中急性获益的TD患者。

相似文献

1
Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism.抗胆碱能药物对迟发性运动障碍及伴发药物性帕金森综合征患者的影响。
J Clin Psychopharmacol. 1989 Dec;9(6):407-11.
2
No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.比哌立登与金刚烷胺对帕金森氏症和迟发性运动障碍型不自主运动的疗效无差异:一项针对药物治疗的慢性精神分裂症患者的双盲交叉、安慰剂对照研究。
J Clin Psychiatry. 1995 Apr;56(4):167-70.
3
A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.一项关于维生素E治疗迟发性运动障碍的双盲安慰剂对照研究。
J Clin Psychiatry. 1996 Apr;57(4):167-73.
4
Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.同时存在抗精神病药物所致震颤和迟发性运动障碍患者的运动障碍:肌电图和药理学研究。
Adv Neurol. 1987;45:361-6.
5
Stable remission of tardive dyskinesia by L-dopa.左旋多巴使迟发性运动障碍稳定缓解。
J Clin Psychopharmacol. 1989 Feb;9(1):39-41.
6
Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.抗精神病药物所致运动障碍和帕金森症的预测因素:测量方法和定义的影响
J Clin Psychopharmacol. 2006 Dec;26(6):560-5. doi: 10.1097/01.jcp.0000245559.14284.e3.
7
Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
J Clin Psychiatry. 1985 Jun;46(6):229-31.
8
Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.普萘洛尔对药物性帕金森震颤的减轻无效。
Mov Disord. 1993;8(1):43-6. doi: 10.1002/mds.870080108.
9
Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.利培酮治疗严重迟发性运动障碍:一项为期12周的随机、双盲、安慰剂对照研究。
J Clin Psychiatry. 2003 Nov;64(11):1342-8.
10
Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.维生素B6治疗迟发性运动障碍:一项初步病例系列研究。
Clin Neuropharmacol. 1999 Jul-Aug;22(4):241-3.

引用本文的文献

1
Resolution of tardive tremor after bilateral subthalamic nucleus deep brain stimulation placement.双侧丘脑底核深部脑刺激植入后迟发性震颤的缓解
Surg Neurol Int. 2020 Dec 16;11:444. doi: 10.25259/SNI_723_2020. eCollection 2020.
2
Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action.氯氮平治疗帕金森病静止性震颤:疗效、不良反应及可能作用机制的综述
Mov Disord Clin Pract. 2015 Dec 30;3(2):116-124. doi: 10.1002/mdc3.12266. eCollection 2016 Mar-Apr.
3
Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
用于抗精神病药物所致迟发性运动障碍的抗胆碱能药物。
Cochrane Database Syst Rev. 2018 Jan 17;1(1):CD000204. doi: 10.1002/14651858.CD000204.pub2.
4
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.帕金森震颤的震颤下颌运动模型的药理学和生理学特征:对震颤病理生理学的潜在见解。
Front Syst Neurosci. 2011 Jul 4;5:49. doi: 10.3389/fnsys.2011.00049. eCollection 2011.
5
Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.非典型抗精神病药物所致锥体外系症状:发生率、预防及管理
Drug Saf. 2005;28(3):191-208. doi: 10.2165/00002018-200528030-00002.
6
Oral movement patterns induced in rats by local infusions into striatum depend upon the regimen of prior neuroleptic exposure.通过向纹状体局部注射药物在大鼠中诱导产生的口腔运动模式取决于先前接触抗精神病药物的方案。
Psychopharmacology (Berl). 1995 Sep;121(2):259-66. doi: 10.1007/BF02245637.
7
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.抗精神病药物治疗后大鼠持续的空嚼行为:与多巴胺能和胆碱能功能的关系。
Psychopharmacology (Berl). 1993;113(2):157-66. doi: 10.1007/BF02245692.